Hopital Robert Debre - Service de Chirurgie Digestive

Centre Hospitalier Universitaire de Reims

Type 1 Diabetes Mellitus

Diabetes Mellitus

Insulet

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous glucose monitor compared to Multiple Daily Injections (MDI) along with the FreeStyle Libre 2 continuous glucose monitor in children and adults with type 1.

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

Centre Hospitalier Universitaire de Reims | Hopital Robert Debre - Service de Chirurgie Digestive

Site insights

Work at this site?

Active trials

Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults (RADIANT)

Trial sponsors